How to treat an old septal infarct (myocardial infarction)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The treatment of an old septal infarct should prioritize a comprehensive approach focused on preventing future cardiac events and managing complications, with a strong emphasis on medical therapy, lifestyle modifications, and regular follow-up with a cardiologist, as recommended by the most recent guidelines 1. The goal of treatment is to prevent remodeling of the heart, reduce the risk of heart failure, and minimize the chance of future cardiac events by addressing the underlying atherosclerotic disease process.

  • Medical therapy includes:
    • Daily aspirin (81-325mg) for antiplatelet therapy
    • A statin medication like atorvastatin (20-80mg daily) to lower cholesterol
    • An ACE inhibitor such as lisinopril (5-40mg daily) or ARB if ACE inhibitors aren't tolerated
    • Beta-blockers like metoprolol (25-200mg daily) to reduce heart workload
  • For patients with reduced ejection fraction, additional medications may include:
    • Aldosterone antagonists like spironolactone (25mg daily)
    • SGLT2 inhibitors
  • Lifestyle modifications are essential, including:
    • Smoking cessation
    • Regular moderate exercise (30 minutes most days)
    • Heart-healthy Mediterranean diet
    • Weight management
    • Stress reduction
  • Regular follow-up with a cardiologist is necessary to monitor cardiac function through echocardiograms and adjust medications as needed, as supported by guidelines from the European Society of Cardiology 1. In cases where mechanical complications arise, such as ventricular septal rupture, definitive surgical correction is frequently the treatment of choice, with the use of temporary mechanical circulatory support (MCS) devices to enhance hemodynamic stabilization and allow for consideration of delayed corrective strategy 1.

From the FDA Drug Label

Myocardial Infarction Metoprolol tartrate injection is indicated in the treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality.

DOSAGE & ADMINISTRATION Myocardial Infarction Early Treatment During the early phase of definite or suspected acute myocardial infarction, initiate treatment with metoprolol tartrate as soon as possible after the patient’s arrival in the hospital.

The treatment for old septal infarct is not directly addressed in the provided drug labels. However, for myocardial infarction, metoprolol tartrate can be initiated as soon as the patient's clinical condition allows, or within 3 to 10 days of the acute event 2. The dosage and administration for myocardial infarction are outlined in the drug label, including intravenous administration and oral maintenance dosage 2.

  • Key points:
    • Initiate treatment as soon as possible after the patient's arrival in the hospital
    • Start with intravenous administration of metoprolol tartrate injection
    • Monitor blood pressure, heart rate, and electrocardiogram during intravenous administration
    • Initiate oral maintenance dosage after intravenous dose However, since the question is about old septal infarct, and there is no direct information in the drug labels to support the treatment of this specific condition, a conservative clinical decision would be to not make any conclusions about the treatment of old septal infarct based on the provided information 2, 2.

From the Research

Treatment of Old Septal Infarct

  • The treatment of old septal infarct is not directly addressed in the provided studies, but some information can be inferred from the discussion of related topics.
  • According to 3, ACE inhibitors such as lisinopril have been shown to reduce mortality and cardiovascular morbidity in patients with myocardial infarction when administered as early treatment.
  • The study 4 discusses the efficacy of septal ablation in patients with hypertrophic obstructive cardiomyopathy, which may be relevant to the treatment of septal infarcts.
  • The combination of beta-blockers and ACE inhibitors is discussed in 5 as a potential treatment for various cardiovascular diseases, including hypertension and heart failure.
  • The study 6 provides an overview of hypertension and acute myocardial infarction, and notes that renin-angiotensin-aldosterone system blockade may be beneficial in high-risk hypertensive patients.
  • The conservative management of patients with acute myocardial infarction and spontaneous acute patency of the infarct-related artery is discussed in 7, which may be relevant to the treatment of old septal infarct.

Potential Treatment Options

  • ACE inhibitors such as lisinopril may be beneficial in reducing mortality and cardiovascular morbidity in patients with old septal infarct.
  • Septal ablation may be considered in patients with hypertrophic obstructive cardiomyopathy and septal infarct.
  • The combination of beta-blockers and ACE inhibitors may be a potential treatment option for patients with old septal infarct and related cardiovascular conditions.
  • Conservative management may be appropriate in some cases, particularly if the patient has spontaneous patency of the infarct-related artery.

Related Questions

What is the recommendation for a patient presenting with exertional dyspnea and pallor, with an elevated B-type Natriuretic Peptide (BNP) level and a previously documented 15% decrease in Ejection Fraction (EF) on echocardiogram?
What is the most appropriate screening test for a 34-year-old woman with elevated blood pressure (hypertension), a family history of hypertension, and no other significant past medical history, presenting for follow-up evaluation?
What is the best next step in managing hypertension in a 51-year-old female with hypertension (HTN) and hyperlipidemia (HLD) who is currently taking amlodipine (NORVASC) 5 mg, atorvastatin (LIPITOR) 10 mg, and has recently experienced elevated blood pressure?
What is the next step in managing a 52-year-old female with a strong family history of Coronary Artery Disease (CAD), who experiences chest pain (CP) with exertion, has a negative troponin (trop) level, a negative Holter (holter) monitor, grade 1 diastolic dysfunction on echocardiogram (Echo), negative nuclear imaging, but exhibits electrocardiogram (EKG) changes and chest pain during the stress test on a treadmill?
What is the diagnosis and management plan for a patient with a history of normal myocardial perfusion study, normal ejection fraction (EF) with mild left ventricular hypertrophy (LVH) and impaired relaxation filling pattern, mild aortic valve calcification, and moderate mitral valve calcification, presenting with shortness of breath, 1+ to 2+ pitting edema, and currently taking Furosemide (Lasix) 20 milligrams (mg) daily?
What is the dose of diclofenac (Diclofenac) suppository before Endoscopic Retrograde Cholangiopancreatography (ERCP)?
What is the dose of Diclofenac (Voltaren) sodium suppository before Endoscopic Retrograde Cholangiopancreatography (ERCP)?
What are the symptoms of acute angle-closure glaucoma?
What is the significance of clinical experience among Physical Therapy (PT) educators?
What are the causes of an elevated D-dimer (D-dimer) level, indicating hypercoagulability or thrombosis?
What is the diagnosis and treatment for Mesenteric Adenitis (inflammation of the mesenteric lymph nodes)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.